Published in Eur Cell Mater on April 04, 2014
Developments in intervertebral disc disease research: pathophysiology, mechanobiology, and therapeutics. Curr Rev Musculoskelet Med (2015) 0.78
Novel cytogenic and neurovascular niches due to blood-brain barrier compromise in the chronic pain brain. Mol Pain (2015) 0.75
Thymoma production of T cell growth factor (Interleukin 2). J Immunol (1980) 5.58
Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1. J Immunol (1982) 2.90
Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF). J Immunol (1981) 2.74
Gene targeting in plants. EMBO J (1988) 2.33
A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med (1997) 2.14
Lymphokines: their role in lymphocyte responses. Properties of interleukin 1. Fed Proc (1982) 1.90
Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines. J Immunol (1981) 1.88
Cellular origin of interleukin 2 (IL 2) in man: evidence for stimulus-restricted IL 2 production by T4+ and T8+ T lymphocytes. J Immunol (1982) 1.87
miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene (2008) 1.86
Interleukin 2 dependence of human natural killer (NK) cell activity. J Immunol (1983) 1.79
The meiotic recombination hot spot created by the single-base substitution ade6-M26 results in remodeling of chromatin structure in fission yeast. Genes Dev (1997) 1.70
Climbing the Jaynes-Cummings ladder and observing its nonlinearity in a cavity QED system. Nature (2008) 1.55
Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immunol (2001) 1.41
Two-qubit state tomography using a joint dispersive readout. Phys Rev Lett (2009) 1.37
Implementation of a Toffoli gate with superconducting circuits. Nature (2011) 1.35
Organotypic keratinocyte cocultures in defined medium with regular epidermal morphogenesis and differentiation. J Invest Dermatol (1999) 1.32
Human genetics and human rights. Identifying the families of kidnapped children. Am J Forensic Med Pathol (1984) 1.27
Deterministic quantum teleportation with feed-forward in a solid state system. Nature (2013) 1.25
Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). II. Functional properties of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions. Cell Immunol (1984) 1.22
Epidermal differentiation and basement membrane formation by HaCaT cells in surface transplants. Eur J Cell Biol (1998) 1.20
Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodies. J Immunol (1982) 1.18
Differential modulation of epidermal keratinization in immortalized (HaCaT) and tumorigenic human skin keratinocytes (HaCaT-ras) by retinoic acid and extracellular Ca2+. Differentiation (1993) 1.14
Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line. J Invest Dermatol (1983) 1.12
Effect of recombinant human interleukin 4 on spontaneous in vitro human IgE synthesis. Eur J Immunol (1988) 1.11
Control and tomography of a three level superconducting artificial atom. Phys Rev Lett (2010) 1.08
Role of hypoxia and growth and differentiation factor-5 on differentiation of human mesenchymal stem cells towards intervertebral nucleus pulposus-like cells. Eur Cell Mater (2011) 1.07
Contribution of the N-acetyltransferase 2 polymorphism NAT2*6A to age-related hearing impairment. J Med Genet (2007) 1.07
Factor-dependent in vitro growth of human normal bone marrow-derived basophil-like cells. J Exp Med (1983) 1.04
Family-based association test method: age of onset traits and covariates. Genet Epidemiol (2001) 1.04
CHO expression of a novel human recombinant IgG1 anti-RhD antibody isolated by phage display. Br J Haematol (2000) 1.01
Cultures of purified human natural killer cells: growth in the presence of interleukin 2. Cell Immunol (1982) 0.98
Anti-amiodarone antibodies: detection and relationship to the development of side effects. Am J Med (1988) 0.97
Observation of resonant photon blockade at microwave frequencies using correlation function measurements. Phys Rev Lett (2011) 0.95
Interleukin 2-independent stimulation of rabbit chondrocyte collagenase and prostaglandin E2 production by an interleukin 1-like factor. Eur J Immunol (1984) 0.95
Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes. Allergy (2011) 0.94
Stimulation-dependent lymphokine mRNA levels in human mononuclear cells. Eur J Immunol (1988) 0.94
Oral anti-IgE immunization with epitope-displaying phage. Eur J Immunol (2000) 0.93
Cytokine mRNA levels in antigen-stimulated peripheral blood mononuclear cells. Eur J Immunol (1989) 0.93
Flow-cytometric analysis of human basophil degranulation. II. Degranulation induced by anti-IgE, anti-IgG4 and the calcium ionophore A23187. Clin Allergy (1981) 0.92
IgE hidden in immune complexes with anti-IgE autoantibodies in children with asthma. J Allergy Clin Immunol (1991) 0.92
HLA and IDDM predisposition: new aspects. Genet Epidemiol Suppl (1986) 0.91
Docetaxel extravasation. Support Care Cancer (2001) 0.91
Dressed collective qubit states and the Tavis-Cummings model in circuit QED. Phys Rev Lett (2009) 0.91
Observation of two-mode squeezing in the microwave frequency domain. Phys Rev Lett (2011) 0.91
Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease. Rheumatology (Oxford) (2004) 0.90
Allergen mimotopes in food enhance type I allergic reactions in mice. FASEB J (1999) 0.90
Lymphokine production by human peripheral blood lymphocytes: analysis by in situ hybridization. Lymphokine Res (1988) 0.90
Description of the Genetic Analysis Workshop 10 bipolar disorder linkage data sets. Genet Epidemiol (1997) 0.89
The REV2 gene of Saccharomyces cerevisiae: cloning and DNA sequence. Curr Genet (1992) 0.89
Production of hemopoietic growth factors by bone tissue and bone cells in culture. J Bone Miner Res (1988) 0.89
Cell cycle associated changes in histamine release from rat basophilic leukemia cells separated by counterflow centrifugal elutriation. J Immunol (1983) 0.89
Synthesis of biologically active interleukin 2 by Xenopus oocytes in response to poly(A)-RNA from a gibbon T-cell line. J Biol Chem (1982) 0.88
Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein. Allergy (2011) 0.88
Resolving vacuum fluctuations in an electrical circuit by measuring the Lamb shift. Science (2008) 0.88
Epitope-specific antibody response to IgE by mimotope immunization. J Immunol (1998) 0.87
Increased level of antibodies cross-reacting with Ves v 5 and CRISP-2 in MAR-positive patients. Int Arch Allergy Immunol (2012) 0.87
The clinical course of lung metastases from breast cancer. Klin Wochenschr (1988) 0.86
Mismatch repair in Schizosaccharomyces pombe requires the mutL homologous gene pms1: molecular cloning and functional analysis. Genetics (1997) 0.86
A mimotope defined by phage display inhibits IgE binding to the plant panallergen profilin. Eur J Immunol (1998) 0.86
Cytofluorometric analysis of macrophages activated in vivo or in vitro. Eur J Immunol (1978) 0.86
Valsartan: long-term efficacy and tolerability compared to lisinopril in elderly patients with essential hypertension. Clin Exp Hypertens (1997) 0.86
Assessment of nutritional status at the time of diagnosis in patients treated for head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis (2012) 0.85
Natural anti-IgE auto-antibodies interfere with diagnostic IgE determination. Clin Exp Allergy (1990) 0.85
Dot-immunobinding assay with monoclonal anti-IgE antibodies for the detection and quantitation of human IgE. J Immunol Methods (1986) 0.84
Quantum-to-classical transition in cavity quantum electrodynamics. Phys Rev Lett (2010) 0.84
Recombination fractions in the HLA system based on the data set 'provinces Françaises': indications of haplotype-specific recombination rates. Eur J Immunogenet (1994) 0.84
Gastric emptying of solids and liquids in obesity. Clin Investig (1993) 0.83
Effect of schistosome-derived inhibitory factor on the cell cycle of T lymphocytes. Int Arch Allergy Appl Immunol (1987) 0.83
Interfering factors to sensitivity and specificity of bronchial reactivity in children. Pediatr Allergy Immunol (1993) 0.82
Selection dynamics in autocatalytic systems: templates replicating through binary ligation. Bull Math Biol (1998) 0.82
Cavity quantum electrodynamics with separate photon storage and qubit readout modes. Phys Rev Lett (2010) 0.82
Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 years. Allergy (1993) 0.82
Conditional autoimmunity mediated by human natural anti-Fc(epsilon)RIalpha autoantibodies? FASEB J (2001) 0.82
Human anti-IgE antibodies by repertoire cloning. Eur J Immunol (1994) 0.82
Organotypic and epidermal-dermal co-cultures of normal human keratinocytes and dermal cells: Regulation of transforming growth factor alpha, beta1 and beta2 mRNA levels. Toxicol In Vitro (1994) 0.82
Neuropeptides are potent modulators of human in vitro immunoglobulin E synthesis. Eur J Immunol (1994) 0.82
Quantitative determination of total and specific human IgE with the use of monoclonal antibodies. J Allergy Clin Immunol (1986) 0.81
Detection of cytokine mRNA in polyclonally-, antigen- or allergen-stimulated mononuclear cells. Immunol Rev (1991) 0.81
Thymocyte activation by cytokines: direct assessment of G0-G1 transition by flow-cytometry. Cell Immunol (1980) 0.81
Factors influencing human IgE synthesis in vitro and in vivo. Int Arch Allergy Appl Immunol (1985) 0.81
Natural anti-FcepsilonRIalpha autoantibodies isolated from healthy donors and chronic idiopathic urticaria patients reveal a restricted repertoire and autoreactivity on human basophils. Hum Antibodies (2001) 0.81
[Propionic acidemia and sensorineural hearing loss: is there a connection at the molecular genetics level?]. HNO (2008) 0.81
Culture and IgE synthesis of nasal B cells. Int Arch Allergy Immunol (1996) 0.80
Does predation risk influence habitat use by northern redbelly dace Phoxinus eos at different spatial scales? J Fish Biol (2009) 0.80
Genetic polymorphisms of properdin factor B(Bf), the second component (C2), and the fourth component (C4) of complement in leprosy patients and healthy controls from Thailand. Immunobiology (1980) 0.80
Characterization of a monoclonal antibody directed against the biologically active site of human interleukin 1. J Exp Med (1986) 0.79
Distinction of the human basophil promoting activity from human interleukin-3. Int Arch Allergy Appl Immunol (1985) 0.79
A long-term follow-up study of hyposensitization with immunoblotting. J Allergy Clin Immunol (1990) 0.79
Recombinant anti-idiotypic antibodies inhibit human natural anti-glycoprotein (GP)IIb/IIIa autoantibodies. J Autoimmun (2002) 0.79
Differential expression of cytokine mRNAs in human cell lines. Lymphokine Res (1989) 0.79
Human anti-FcepsilonRIalpha autoantibodies isolated from healthy donors cross-react with tetanus toxoid. Eur J Immunol (1999) 0.79
Anti-IgE autoantibodies and bee-sting allergy. Allergy (1995) 0.79
Fructose malabsorption in children with recurrent abdominal pain: positive effects of dietary treatment. Klin Padiatr (2011) 0.79
Regulatory effect of recombinant interleukin (IL)3 and IL4 on cytokine gene expression of bone marrow and peripheral blood mononuclear cells. Eur J Immunol (1989) 0.78
Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma. Int Arch Allergy Immunol (1996) 0.78
Recombinant human natural autoantibodies against GPIIb/IIIa inhibit binding of autoantibodies from patients with AITP. Br J Haematol (1998) 0.78
Anti-IgE autoantibodies mistaken for specific IgG. J Allergy Clin Immunol (1992) 0.78
IgE autoantibodies in atopic dermatitis--occurrence of different antibodies against the CH3 and the CH4 epitopes of IgE. Allergy (1995) 0.78
Molecular mimicry of the unidentified antigen of myeloma antibody IgE-ND. Eur J Immunol (1999) 0.78